Pharma Packaging

EMA is working closely with the company, with experts in blood disorders, and with other health authorities including the UK’s MHRA based on its experience with around 11 million administered doses of the vaccine.

The passive temperature control packaging solutions for the pharmaceutical, life science and cold chain logistics industries supported Pfizer with the development of the highly specialised and reusable ultra-low temperature (ULT) shipper to help them on the distribution of ultra-low temperature vaccines and storing them at Point of Use (POU) sites.

Ultra-Low Temperature vaccines, such as that developed by Pfizer – BioNTech, uses mRNA (messenger RNA) technology and must be stored at temperatures between -90°C to -60°C to ensure that the vaccine’s quality and efficacy is maintained.

An especially designed plastic - polyethylene terephthalate or PET is widely used for packaging water, medicines, beverages, edible oil, etc across the world because of its safety, utility and economic viability for the packaging of products of mass consumption. PET is a clear, strong, safe, lightweight and completely recyclable plastic belonging to the polyester family.

The new solution is available in plastic tube diameters ranging from 30-50mm, and in four substrate varieties: polyethylene and recycled tubes, each with or without EVOH barrier.

The reduction of material usage is most apparent in the tube’s wall thickness, which has been reduced from 0.5 mm to 0.35 mm without, Neopac says, sacrificing “exemplary” haptics. Low profile closures are already in the pipeline with the aim of achieving maximum weight reduction in plastic tubes.

Constantia Flexibles has announces a new product called Perpetua, a sustainable high-barrier packaging solution for pharma products. It is the company’s first recyclable polymeric mono-material, has a wide range of uses in pharma packaging applications and is now available worldwide. Perpetua offers excellent product protection from oxygen, water vapor and light.

The D-Flex™ Ecosystem consists of the D-Flex™ injection pen, a connected cap, a mobile app and the Haselmeier™ data platform. The connected cap collects data at the point of care, securely transferring it to the mobile app and from there to any platform. In this way D-Flex™ Ecosystem enables real-time monitoring and advanced analytics in clinical trials.

Meet our D-Flex™ Ecosystem. It collects treatment data at the point of care, automatically transferring it to any platform, giving controlled access to various stakeholders.

Crystal Lake, Illinois, February 18, 2021 — AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual results for 2020 and highlighted the resiliency of the Company’s business model throughout the COVID-19 pandemic.

Fourth Quarter 2020 Summary

High protection levels against moisture, oxygen and heat are important for protecting active pharmaceutical ingredients (APIs), to provide the patient with an effective medication. Constantia Flexibles’ goal was to meet the very high barrier properties for pharma products, while implementing the best possible sustainability standards. The result is Perpetua, a recyclable product family, based on a unique line of full PP (Polypropylene) high barrier laminates. The flexible packaging solution is available in application-tailored versions.